Literature DB >> 2600213

Aeroallergen contact can exacerbate atopic dermatitis: patch tests as a diagnostic tool.

R A Clark1, A D Adinoff.   

Abstract

Previous studies have documented that atopic dermatitis can worsen when patients ingest specific foods to which they are sensitive. In this article we demonstrate that patient contact with specific aeroallergens can cause flares of atopic dermatitis. Marked improvement in skin symptoms was noted when 12 patients (eight males and four females; ages, 1 to 54 years) were removed from their unusual environment. In response to prick tests, these patient had markedly positive, immediate wheel-and-flare reactions to a variety of aeroallergen extracts (tree, grass, and weed pollen; house dust mite; animal protein; and mold spores). The same patients were subsequently patch tested on uninvolved, nonabraded skin with the allergen extracts that had yielded positive prick tests. Patch tests were applied for 48 hours, removed, and interpreted 24 hours later. The patients reacted to specific aeroallergens with an eczematous eruption at 48 and 72 hours. Positive delayed cutaneous reactions correlated strongly with aeroallergens identified in the patient's environment or suspected by the patients as provocateurs of their atopic dermatitis. Delayed cutaneous reactions were negative to allergens not historically relevant. Continued avoidance of aeroallergens that elicited an eczematous reaction at patch test sites resulted in marked improvement or resolution of dermatitis in all patients. We conclude that aeroallergen contact plays an important role in select patients with atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600213     DOI: 10.1016/s0190-9622(89)70269-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  The role of airborne proteins in atopic dermatitis.

Authors:  Sarah Grim Hostetler; Benjamin Kaffenberger; Todd Hostetler; Matthew J Zirwas
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

Review 2.  Atopic dermatitis and delayed hypersensitivity to dust mites.

Authors:  M Castelain
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 3.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

4.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.

Authors:  J M Spergel; E Mizoguchi; J P Brewer; T R Martin; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 5.  IgE, mast cells, and eosinophils in atopic dermatitis.

Authors:  Fu-Tong Liu; Heidi Goodarzi; Huan-Yuan Chen
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

Review 6.  [Atopic patch test. Atopic eczema and allergy].

Authors:  U Darsow; J Ring
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

7.  Airborne contact dermatitis - current perspectives in etiopathogenesis and management.

Authors:  Sanjeev Handa; Dipankar De; Rahul Mahajan
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

8.  Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells.

Authors:  Michael R Ardern-Jones; Antony P Black; Elizabeth A Bateman; Graham S Ogg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

9.  Immunoglobulin e-mediated allergy plays a role in atopic eczema as shown in the atopy patch test.

Authors:  Ulf Darsow; Johannes Ring
Journal:  World Allergy Organ J       Date:  2008-03       Impact factor: 4.084

10.  Aeroallergen patch testing in patients of suspected contact dermatitis.

Authors:  Nelee Bisen; Shrutakirthi D Shenoi; C Balachandran
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.